| Magnesium-enriched hydroxyapatite versus autologous bone in maxillary sinus grafting: combining histomorphometry with osteoblast gene expression profiles ex vivo. | |
| | |
MedLine Citation:
|
PMID: 19335078 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Many biomaterials are proposed for sinus floor lifting and grafting in the posterior maxilla for insufficient bone volume (BV). The aim of this study was to compare the use of magnesium-enriched hydroxyapatite (mHA) versus autogenous bone graft (AB) for maxillary sinus lift procedures by histomorphometric and ex vivo gene expression profiling. METHODS: Fifteen patients requiring bilateral maxillary sinus augmentation received autologous bone particles (group A) and mHA (group B) (split-mouth design). Five months later, implants were placed, and biopsies were obtained. Bone specimens were analyzed by histomorphometry, BV and vital bone (VB) percentages were calculated, and ex vivo osteoblast expansion followed by highly sensitive osteoblast specific gene expression profiling for cbfa1, osteocalcin, osteopontin, collagen type I, receptor activator of nuclear factor-kappa B ligand (RANKL), and osteoprotegerin (OPG) by quantitative real-time reverse transcription-polymerase chain reaction (RT-PCR) were performed. Comparisons were made using the Student t test. RESULTS: After healing with no complications, BV was comparable in the two groups (80.79% +/- 14.27% for autologous versus 76.72% +/- 11.47% for mHA; P = not statistically significant), but VB was lower in the mHA group (29.65% +/- 9.81% versus 78.40% +/- 16.72%; P <0.05). Real-time RT-PCR analyses showed significantly higher expression of the osteoblast differentiation factor Cbfa1 and the matrix formation marker osteocalcin in the mHA group compared to the AB group, whereas type I collagen was comparable, and osteopontin was decreased. Attesting to a lower osteoclastogenic potential, the RANKL/OPG ratio was diminished. CONCLUSIONS: Autogenous bone samples provided higher vital over comparable total bone levels than mHA-grafted sites. Osteoblast gene expression profiles from mHA grafts revealed higher expression of certain specific markers of osteoblast differentiation and bone formation, associated with a lower osteoclastogenic potential. |
| | |
Authors:
|
Roberto Crespi; Elisabetta Mariani; Elisa Benasciutti; Paolo Capparè; Simone Cenci; Enrico Gherlone |
Related Documents
:
|
11519708 - Efficacy of porous bovine bone mineral in various types of osseous deficiencies: clinic... 10923298 - Mechanical properties of a biodegradable bone regeneration scaffold. 17298488 - Bone healing in critical-size defects treated with bioactive glass/calcium sulfate: a h... 20569048 - Follistatin as a potent regulator of bone metabolism. 21457868 - Rootless eruption of a mandibular permanent canine. 18157038 - Locking plate fixation for pediatric femur fractures. |
Publication Detail:
|
Type: Comparative Study; Journal Article; Randomized Controlled Trial |
Journal Detail:
|
Title: Journal of periodontology Volume: 80 ISSN: 0022-3492 ISO Abbreviation: J. Periodontol. Publication Date: 2009 Apr |
Date Detail:
|
Created Date: 2009-04-01 Completed Date: 2009-07-20 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8000345 Medline TA: J Periodontol Country: United States |
Other Details:
|
Languages: eng Pagination: 586-93 Citation Subset: D; IM |
Affiliation:
|
Department of Dentistry, San Raffaele Scientific Institute and University Vita-Salute San Raffaele, Milan, Italy. robcresp@libero.it |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Bone Regeneration
/
genetics* Bone Substitutes / chemistry* Bone Transplantation Collagen Type I / biosynthesis Core Binding Factor Alpha 1 Subunit / biosynthesis Durapatite / chemistry* Female Gene Expression Profiling Humans Magnesium Male Maxillary Sinus / surgery* Middle Aged Oral Surgical Procedures, Preprosthetic / methods* Osteoblasts / metabolism Osteocalcin / biosynthesis Osteopontin / biosynthesis Osteoprotegerin / biosynthesis RANK Ligand / biosynthesis Reverse Transcriptase Polymerase Chain Reaction |
| Chemical | |
Reg. No./Substance:
|
0/Bone Substitutes; 0/Collagen Type I; 0/Core Binding Factor Alpha 1 Subunit; 0/Osteoprotegerin; 0/RANK Ligand; 104982-03-8/Osteocalcin; 106441-73-0/Osteopontin; 1306-06-5/Durapatite; 7439-95-4/Magnesium |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Hand and ultrasonic instrumentation in combination with root-coverage surgery: a comparative control...
Next Document: Circulating interleukin-6 and high-sensitivity C-reactive protein decrease after periodontal therapy...